197 related articles for article (PubMed ID: 34515612)
1. miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1).
Ding Y; Wang J; Lu J
Bioengineered; 2021 Dec; 12(1):6771-6781. PubMed ID: 34515612
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
3. Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.
Pan J; Xu Z; Guo G; Xu C; Song Z; Li K; Zhong K; Wang D
Bioengineered; 2021 Dec; 12(1):5373-5385. PubMed ID: 34468254
[TBL] [Abstract][Full Text] [Related]
4. MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR.
Zeng J; Wang L; Zhao J; Zheng Z; Peng J; Zhang W; Wen T; Nie J; Ding L; Yi D
Hum Cell; 2021 Sep; 34(5):1388-1397. PubMed ID: 34138410
[TBL] [Abstract][Full Text] [Related]
5. MiR-26a-5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17.
Shi H; Li H; Zhang F; Xue H; Zhang Y; Han Q
Cell Biol Int; 2021 Nov; 45(11):2357-2367. PubMed ID: 34370360
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1.
Liu S; Su L; Li J; Zhang Y; Hu X; Wang P; Liu P; Ye J
Mol Cell Endocrinol; 2024 Aug; 589():112252. PubMed ID: 38649132
[TBL] [Abstract][Full Text] [Related]
7. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
8. Involvement of microRNA-23b-5p in the promotion of cardiac hypertrophy and dysfunction via the HMGB2 signaling pathway.
Boureima Oumarou D; Ji H; Xu J; Li S; Ruan W; Xiao F; Yu F
Biomed Pharmacother; 2019 Aug; 116():108977. PubMed ID: 31103821
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
10. MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
Xu M; Liu D; Gao X; Wang Z; Zhang L; Fan H
Tohoku J Exp Med; 2023 Feb; 259(3):199-208. PubMed ID: 36517015
[TBL] [Abstract][Full Text] [Related]
11. MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
Wang W; Wu C; Ren L; Bao Y; Han Y; Li C; Li Y
Exp Cell Res; 2020 Sep; 394(2):112140. PubMed ID: 32535037
[TBL] [Abstract][Full Text] [Related]
12. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
[TBL] [Abstract][Full Text] [Related]
13. MiR-625-5p Inhibits Cardiac Hypertrophy Through Targeting STAT3 and CaMKII.
Cai K; Chen H
Hum Gene Ther Clin Dev; 2019 Dec; 30(4):182-191. PubMed ID: 31617427
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-339-5p promotes isoproterenol-induced cardiomyocyte hypertrophy by targeting VCP to activate the mTOR signaling.
Bi X; Zhang Y; Yu Y; Yuan J; Xu S; Liu F; Ye J; Liu P
Cell Biol Int; 2022 Feb; 46(2):288-299. PubMed ID: 34854520
[TBL] [Abstract][Full Text] [Related]
16. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
18. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
19. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
Lu Y; Wu F
Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
[TBL] [Abstract][Full Text] [Related]
20. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
Xu X; Wang J; Wang X
Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
